English: Logo of Pfizer Incorporated. (Photo credit: Wikipedia)
Manila – Pharmaceutical firm Pfizer has voluntarily recalled cough syrup Robitussin DM from the market due to erroneous labeling. The product contains 15 milligrams of Dextromethorphan HB2 and 100 milligrams of Guaifenesin per 5 ml. Deztromethorphan is a cough suppressant and Guaifenesin in an expectorant. Based on the Food and Drug administration, their is a discrepancy in dosage instructions in the primary label and the carton.
The wrong label had an indication that children between 2 and 6 year olds should take 2.5 ml or 1 teaspoon every 4 hours when the right dosage is half the amount. Since the drug is sold over the counter, many parents rely on the labels for the dosage. People using the affected product are advised to discontinue using it. It is also best to consult a doctor to check for the right dosage for a child.
Dextromethorphan overdose could have symptoms like Breathing problems, convulsions, dizziness, rapid heartbeat, and vomiting.
Related articles
- Pfizer recalls Robitussin DM products – FDA (business.inquirer.net)
- FDA Mulls Curbs on Cough Syrup Used for Robotripping (blogs.lawyers.com)
- Cough Medicine for Colds (everydayhealth.com)
- Teens vomit while ‘robotripping’ on DXM cough syrup in PSA; Dextromethorphan has sickening side effects (purestrange.wordpress.com)
- Cold Remedies for Kids: 4 Natural Products to Alleviate Symptoms (savings.com)
- 5 years’ jail for selling cough syrup (todayonline.com)
